Thirty-Year Trends in Mortality from Cerebrovascular Diseases in Korea

다국어 초록 (Multilingual Abstract)

Background and Objectives: Cerebrovascular disease is a leading cause of mortality and morbidity in Korea. Understanding of cerebrovascular disease mortality trends is important to reduce the health burden from cerebrovascular diseases. We examined the changing pattern of mortality related to cerebrovascular disease in Korea over 30 years from 1983 to 2012.
Subjects and Methods: Numbers of deaths from cerebrovascular disease, hemorrhagic stroke, and cerebral infarction were obtained from the national Cause of Death Statistics. Crude and age-adjusted mortality rates were calculated for men and women for each year.
Penalized B-spline methods, which reduce bias and variability in curve fitting, were used to identify the trends of 30-year mortality and identify the year of highest mortality.
Results: During the 30 years, cerebrovascular disease mortality has markedly declined. The age-adjusted cerebrovascular disease mortality rate has decreased by 78% in men and by 68% in women. In the case of hemorrhagic stroke, crude mortality peaked in 2001 but ageadjusted mortality peaked in 1994. Between 1994 and 2012, age-adjusted mortality from hemorrhagic stroke has decreased by 68% in men and 59% in women. In the case of cerebral infarction, crude and age-adjusted mortality rates steeply increased until 2004 and 2003, respectively, and both rates decreased rapidly thereafter.
Conclusion: Cerebrovascular disease mortality rate has significantly decreased over the last 30 years in Korea, but remains a health burden. The prevalence of major cardiovascular risk factors are still highly prevalent in Korea.

참고문헌 (Reference)

1 박태환, "한국인에서 허혈성 뇌졸중에 대한 주요 위험인자들의 인구기여위험도" 대한뇌졸중학회 10 (10): 125-133, 2008

2 원태영, "사망 통계자료의 정확성에 대한 연구" 대한응급의학회 18 (18): 256-262, 2007

3 Kim HJ, "Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: results from the Korea National Health and Nutrition Examination Survey, 1998-2012" 174 : 64-72, 2014

4 Lever AF, "Treatment of hypertension in the elderly" 13 : 571-579, 1995

5 이승원, "Thirty-Year Trends in Mortality from Cardiovascular Diseases in Korea" 대한심장학회 45 (45): 202-209, 2015

6 Deaton C, "The global burden of cardiovascular disease" 10 (10): S5-S13, 2011

7 Garraway WM, "The continuing decline in the incidence of stroke" 58 : 520-523, 1983

8 Harmsen P, "Stroke incidence rates were unchanged, while fatality rates declined, during 1971-1987 in Göteborg, Sweden" 23 : 1410-1415, 1992

9 Koton S, "Stroke incidence and mortality trends in US communities, 1987 to 2011" 312 : 259-268, 2014

10 Towfighi A, "Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead" 42 : 2351-2355, 2011

11 Keun-Sik Hong, "Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke" 대한뇌졸중학회 15 (15): 2-20, 2013

12 Ní Chróinín D, "Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials" 44 : 448-456, 2013

13 Jung KH, "Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke)" 5 : 327-334, 2012

14 O’Donnell MJ, "Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study" 376 : 112-123, 2010

15 Neaton JD, "Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group" 3 : 493-499, 1993

16 Costa MJ, "Penalized spline models and applications" University of Warwick 2008

17 김현창, "Noncommunicable Diseases: Current Status of Major Modifiable Risk Factors in Korea" 대한예방의학회 46 (46): 165-172, 2013

18 Levi F, "Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update" 16 : 333-350, 2009

19 Sarti C, "International trends in mortality from stroke, 1968 to 1994" 31 : 1588-1601, 2000

20 Bonita R, "Increased treatment of hypertension does not explain the decline in stroke mortality in the United States, 1970-1980" 13 (13): 169-173, 1989

21 Carter KN, "Improved survival after stroke: is admission to hospital the major explanation? Trend analyses of the Auckland Regional Community Stroke Studies" 23 : 162-168, 2007

22 Thom TJ, "Heart disease, cancer, and stroke mortality trends and their interrelations. An international perspective" 90 : 574-582, 1994

23 Kannel WB, "Framingham study insights into hypertensive risk of cardiovascular disease" 18 : 181-196, 1995

24 Lackland DT, "Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association" 45 : 315-353, 2014

25 Klag MJ, "Decline in US stroke mortality. Demographic trends and antihypertensive treatment" 20 : 14-21, 1989

26 Mirzaei M, "Cerebrovascular disease in 48 countries: secular trends in mortality 1950–2005" 83 : 138-145, 2012

27 Suh I, "Cardiovascular mortality in Korea: a country experiencing epidemiologic transition" 56 : 75-81, 2001

28 Lee KS, "Burden of disease in Korea during 2000-10" 36 : 225-234, 2014

29 Lewington S, "Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies" 360 : 1903-1913, 2002

30 Thijs L, "A metaanalysis of outcome trials in elderly hypertensives" 10 : 1103-1109, 1992